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ABSTRACT
Longitudinal studies for determining the risk of anxiety and depression among COVID-19 survivor healthcare workers are
lacking. This study aimed to determine the risk of anxiety and depression among healthcare workers that survived COVID-19
infection through a six-month post-recovery follow-up. This was a cohort study conducted at the Department of Obstetrics and
Gynecology, Lady Reading Hospital, Peshawar, from 1st March to 30th August 2020. A total of 64 subjects participated. Hospi-
tal Anxiety and Depression Scale (HADS) was used for assessing the anxiety and depression symptoms. HADS has three
score  cutoff  as  normal,  borderline  abnormal  and,  abnormal  anxiety/depression.  For  the  purpose  of  the  study,  borderline  and
above scores were taken as positive for anxiety/depression. Data was analysed using STATA Corp 15.1. There was no increased
risk of anxiety or depression six months post-COVID-19 infection in the infected HCW, compared to uninfected HCW. It is recom-
mended to conduct longitudinal studies with large sample and longer follow-up.  
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The  impact  of  COVID-19  on  mental  health  of  healthcare
workers  (HCWs)  is  a  public  health  issue  of  concern.  It  is
predicted that  the pandemic will  have both short-term and
long-term consequences on the mental health of people.1 Most
of  the  current  evidence  about  the  impact  of  COVID-19  on
mental health is based on cross-sectional studies and very few
longitudinal studies are found. Mazza et al.  hypothesised that
COVID-19  survivors  have  a  high  prevalence  of  psychiatric
illness  after  recovery,  compared to  the general  population.
Four thousand patients were screened one month after hospi-
talisation for COVID-19, and found high rate of anxiety, depres-
sion,  and  PTSD.2  One local  study  reported  increased stress
among HCWs in Peshawar.3 However, studies that determine
the  risk  of  anxiety  and  depression  among  the  COVID-19
survivor HCWs are lacking.  
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This study aimed to determine the risk of anxiety and depres-
sion  among  HCWs  six  months  post-COVID-19  infection
using HADS screening and diagnostic instruments for detec-
tion of anxiety and depression. The primary outcome of this
study was to determine the relative risk of anxiety and depres-
sion among HCWs infected with COVID-19, compared to those
that were uninfected with COVID-19.
This was a cohort study conducted at the Department of Obstet-
rics and Gynecology, Lady Reading Hospital, from 1st March
to  30th  August  2020.  Data  were  collected  from  HCWs  (resi-
dents,  interns,  consultants,  nurses  and,  ancillary  staff).  All
HCWs  COVID-19  PCR  positive  in  March  2020,  were
taken as the exposed group and all HCWs COVID-19 negative
in  March  2020  were  enrolled  as  the  unexposed  group.
HCWs  with  a  prior  history  of  diagnosed  mental
illness  or  on  psychiatric  medications  were  excluded.   Data
were  collected  prospectively.  Both  the  exposed  and  unex-
posed groups were recruited from the same unit to minimise
confounders. Previous pandemics have shown a 10-35% risk -
for developing anxiety and depression post-infection.2 Taking
a margin of error of 5% and confidence level of 95%, risk of
anxiety  and  depression  of  30%  among  exposed,  and  5%
among the unexposed, WHO calculator was used to calculate
the sample size to be 43 among exposed and 43 among unex-
posed group. A convenience sampling technique was used. 
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 Age 0.847 0.94   0.491 0.83
 <35 33a(86.8) 23b(88.5)   35a (85.4) 21b(91.3)   
 >35 5c(13.2) 3d(11.5)   6c(14.6) 2d(8.7)   
 Marital status 0.769 0.93   0.452 1.19
 Married 28a(73.7) 20b(76.9)   32a(78) 16b(69.6)   
 Unmarried 10c(26.3) 6d(23.1)   9c(22) 7d(30.4)   
 Job status   0.935 1.02   0.835 0.95
 Doctor 31a(81.6) 21b(80.8)   33a(80.5) 19b(82.6)   
 Other supporting staff 7c(18.4) 5d(19.2)   8c(19.5) 4d(17.4)   
 Covid status 0.545 0.88   0.352 0.84
 Positive (Exposed) 19a(50) 15b(57.7)   20a(48.8) 14b(60.9)   
 Negative (unexposed) 19c(50) 11d(42.3)   21c(51.2) 9d(39.1)   
 Gender 0.223 -   0.178 -
 Female 38a(100) 25b(96.2)   41a(100) 22b(95.7)   
 Male 0c 1d(3.8)   0 1(4.3)   
 Depression <0.001 0.27   <0.001 2.82
 Yes 5a(13.2) 18b(69.2)   33a(80.5) 5b(21.7)   
 No 33c(86.8) 8d(30.8)   8c(19.5) 18d(78.3)   
+Abbreviation Relative Risk, formula for RR used was [Equation]. a, b, c, d are the cell content for the calculation with above formulas.   Incidence of anxiety
n COVID survivor HCWs = [Equation] = 19/19+15= 0.56 . Incidence of anxiety in non-COVID HCWs = [Equation] = 19/19+11 = 0.63. Relative risk for anxiety among
HCWs who survived COVID infection.  RR= [Equation] = 0.56/0.63 = 0.88. Incidence of depression in COVID survivor HCWs = [Equation] 20/20+14 = 0.59. Incidence of
depression in non COVID HCWs = [Equation] = 21/21+9 = 0.70. Relative risk of developing depression among HCW who survived COVID infection. RR= [Equation] =
0.59/0.70 = 0.84.
Ethical  approval  was  obtained  from  LRH-Ethical  Review
Board in July 2020. Informed consent forms (ICF), were made
both in English and Urdu for easy understanding of the partici-
pants.  Any  identifiers  including  names  or  medical  record
numbers  for  participants  were  removed  from  the  data.
Personal  data  were  de-identified  through  codes.  Information
about basic sociodemographic along with anxiety and depres-
sion using the Hospital Anxiety Depression Scale (HADS) was
gathered.  The  HADS instrument  was  administered  by  two
medical doctors. Data were analysed using STATA Corp 15.1.
(StataCorp, LLC, College Station, TX). Categorical variables w-
ere reported as frequencies and percentages. Anxiety and
depression  scores  were  reported  as  normal,  border-
line, and abnormal scores. The categories of borderline and
abnormal scores were merged to avoid sparse data and for
generating 2x2 tables for disease and exposure status. Cate-
gorical variables were compared using the Chi-square test. P--
values for the two-tailed hypothesis were reported, with p
<0.05  considered  significant.  Relative  risk  was  calculated
manually.   
Eighty-six  participants  were  enrolled  while  65  participants
completed the paper-based HADS questionnaire. Sixty-three-
 (98.6%) participants were females;  84.4% (n=54) partici-
pants  were  25-35  years  of  age;  75%  (n=  48)  were
married. The HADS scores for the 64 study participants can
be seen in Table I.  Twenty-five percentage participants,  who
were initially enrolled in the study, did not complete the six--
month  evaluation,  and  were  excluded  from  the  analy-
sis. The risk of anxiety and depression has been tabulated in
Table  I.  An  insignificant  difference  in  the  risk  of  anxiety
among COVID-19 survivor HCWs was seen as compared to
the  COVID-19  negative  participants.  An  insignificant  differ-
ence  in  the  risk  of  depression  among  COVID-19  survivor
HCWs was seen as compared to the COVID-19 negative parti-
cipants.  The  percentages  of  participants  with  borderline
anxiety  score  (32.8%),  abnormal  anxiety  score  (26.6%),
borderline depression score (28.1%), and abnormal depres-
sion scores (35.9%).  
The present results did not show an increased risk of anxiety
and depression among COVID-19 survivor HCWs, compared
to the uninfected HCWs.  Although longitudinal  studies are
lacking from Pakistan; however, international cross-section-
al studies have been reported.
The presently  reported percentages of  abnormal  anxiety s-
core (26.6%) and depression score (35.9%) among healthcare
workers were higher, compared to a study from China (anxie-
ty 20.1% and depression 12.7%),4 and India (anxiety 3.7% and
depression 11.4%)5; but lower compared to United States (33%
for anxiety and 48% depression).6 
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When compared the findings with the study from Mazza et al.,
they reported 57% anxiety or  depressive symptoms,  which
is higher than this study.2  
There  was  no  sufficient  evidence  to  conclude  that  COVID-19
positive  HCWs had a  higher  risk  of  anxiety  or  depression,
compared to uninfected HCWs. However, this study provides
important findings, upon which future longitudinal studies can
be built. The main strength of this study was its cohort design
and controls, selected from the same unit to limit confounding
factors. Limitations include fewer male participants, a small-
 sample size, and 25% loss to follow-up. A baseline assessment
of the participants with HADS was not done; hence, the undiag-
nosed baseline anxiety or depression cannot be ruled out.  
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